Rev. OFIL 2018, 28;1:79-80 Fecha de recepción: 03/07/2017  –  Fecha de aceptación: 13/09/2017 Meroño Saura MA, Rodríguez Martínez T, Ventura López M, Gómez Gil A Hospital General Universitario Morales Meseguer. Murcia (España) ____ SUMMARY Primary immune thrombocytopenia is an autoimmune disorder produced by two mechanisms; premature platelet destruction mediated by autoantibodies and an impaired platelet … Continue reading Combined use of rituximab and romiplostim in idiopathic thrombocytopenic purpura: report of a case